創薬アウトソーシング市場レポート 2023-2033

Drug Discovery Outsourcing Market Report 2023-2033

レポート詳細創薬アウトソーシング市場レポート 2023-2033 ：本レポートは、業界とその基礎となるダイナミクスをよりよく理解したいと望むなら、新たな収益ポケットを目指す大手企業にとって貴重な... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年6月14日	GBP4,500 部署ライセンスライセンス・価格情報・注文方法はこちら	389	320	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

創薬アウトソーシング市場レポート 2023-2033：本レポートは、業界とその基礎となるダイナミクスをよりよく理解したいと望むなら、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。異業種への進出や新規地域での既存事業の拡大を目指す企業にも有用です。

イノベーションの減少や、研究開発費を全面的に削減しなければならないという財政的圧力の高まりに直面し、製薬会社はトップダウン型のブロックバスター創薬モデルがもはや通用しないことに気づいている。そのため、製薬市場では現在、研究開発のより分配的なモデルへの移行が進んでいる。将来の収益成長を確保するために、製薬業界は初期の創薬に投資を集中させる必要がある。

企業が学術研究所と提携する官民パートナーシップは、その進むべき道として提案されている。このアプローチの利点は、創薬研究の成果が誰でも見られるように公開されることである。このアプローチの利点は、創薬研究の成果が誰でも見られるように公開されることである。これにより、世界のアカデミアの専門知識が活用され、より早く治療法が見つかる可能性がある。

市場調査レポートを購入する前にすべき質問とは？
- 創薬アウトソーシング市場はどのように進化しているのか？
- 創薬アウトソーシング市場の推進要因と阻害要因は何か？
- 各創薬アウトソーシングサブマーケットセグメントは予測期間中にどのように成長し、2033年にどれくらいの収益を占めるようになるのか？
- 2023年から2033年にかけて、創薬アウトソーシングの各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 主要な創薬アウトソーシング市場はマクロ経済の動きに大枠で追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレーヤーは誰か、また予測期間中の見通しは？
- これらの大手企業の創薬アウトソーシングプロジェクトは？
- 2023年から2033年の間に、業界はどのように発展していくのか？創薬アウトソーシングプロジェクトが
現在および今後10年間に実施される創薬アウトソーシングプロジェクトはどのような意味を持つのか？
- 創薬アウトソーシング市場をさらに拡大するために、製品化の必要性は高まっているのか？
- 創薬アウトソーシング市場はどこに向かい、どのようにすれば市場の最前線に立てるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに導くための重要な展望とは？

このことが、現在、そして今後10年間の創薬アウトソーシング市場にどのような影響を与えるかを見極める必要がある：
- 389ページにわたる本レポートでは、134の表と186の図表を掲載しています。
- 本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、創薬アウトソーシング市場が今後10年間でどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展するかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。

2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、最近の動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

サービスタイプ
- 化学サービス
- 生物学サービス

ワークフロー
- ターゲット同定/・スクリーニング
- ターゲット検証・機能インフォマティクス
- リード化合物の同定・候補化合物の最適化
- 前臨床開発
- その他の関連ワークフロー

治療領域
- がん領域
- 感染症
- 中枢神経系
- 免疫学
- 心血管疾患
- 代謝疾患
- 呼吸器疾患
- その他

分子タイプ
- 大分子
- 低分子

エンドユーザー
- 製薬・バイオテクノロジー企業
- 学術機関
- その他

世界市場全体と各分野の収益予測に加え、5つの地域と24の主要国市場の収益予測も掲載している：

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州

アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- 東南アジア
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他のラテンアメリカ

MEA
- GCC
- 南アフリカ
- その他のMEA

本レポートでは、創薬アウトソーシング市場の2023年から2033年にかけての主要企業のプロファイルも掲載しており、これらの企業の事業のこのセグメントに焦点を当てている。

主要企業と市場成長の可能性
・ Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
・ Charles River Laboratories
・ Curia Global, Inc.
・ Dalton Pharma
・ Domainex
・ Eurofins
・ Evotec AG
・ Genscript
・ Jubilant Biosys Ltd.
・ Laboratory Corporation of America Holdings
・ Pharmaron
・ QIAGEN N.V.
・ Selvita
・ Sundia Meditech Co Ltd.
・ Sygnature Discovery
・ Syngene International
・ Thermo Fisher Scientific Inc.
・ WuXi AppTec

創薬アウトソーシング市場全体の世界売上高（金額ベース）、2023年～2033年：市場は2023年に106億4,400万米ドルを超える。2033年まで収益は力強く成長すると予測している。当研究所では、最も大きな可能性を秘めた組織を特定する。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。

創薬アウトソーシング市場、2023-2033年レポートはどのように役立つのか？
要約すると、380ページを超えるこのレポートは、以下の知識を提供する：

- 創薬アウトソーシング市場の2023年〜2033年までの収益予測 - サービスタイプ、ワークフロー、治療分野、分子タイプ、エンドユーザー別に、それぞれ世界および地域レベルで予測 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけます。

- 5つの地域と24の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの創薬アウトソーシング市場の2023年から2033年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。

- 既存企業および市場参入を目指す企業の展望 - 創薬アウトソーシング市場に関わる主要企業18社の企業プロファイルを含む、2023年から2033年までの市場展望。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社のレポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、創薬アウトソーシング市場、2023年から2033年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1 レポート概要
1.1 研究の目的
1.2 創薬アウトソーシング市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り：
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 医薬品・バイオテクノロジー研究開発予算の減少
3.2.1.2 新興国はCROの人気進出先である
3.2.1.3 業界の状況改善は健全な成長を促進する
3.2.1.4 コスト削減：アウトソーシングの中心的原動力
3.2.1.5 新薬候補の発見を加速する
3.2.2 市場抑制要因
3.2.2.1 知的財産保護の制限
3.2.2.2 官民アライアンスの脅威
3.2.3 市場機会
3.2.3.1 戦略的パートナーシップによる有利な成長見通し
3.2.3.2 人工知能への投資が新たな収益ポケットを提供する
3.2.3.3 CRO拡大の可能性
3.2.3.4 ターゲット療法：生物製剤と希少疾病用医薬品の進歩
3.3 COVID-19の影響分析
3.4 研究開発アウトソーシングのビジネスモデル（フィー・フォー・サービス）
3.5 CROと製薬企業のコラボレーション
3.6 ポーターのファイブフォース分析
3.6.1 競争力：高い
3.6.2 代替品の脅威：中
3.6.3 買い手の交渉力: 高
3.6.4 供給者の交渉力：中
3.6.5 新規参入の脅威：中

4 創薬アウトソーシング市場分析：サービスタイプ別
4.1 主要な調査結果
4.2 サービスタイプ別セグメント市場魅力度指数
4.3 サービスタイプ別創薬アウトソーシング市場規模の推定と予測
4.4 化学サービス
4.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 生物学サービス
4.5.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
4.5.2 地域別市場シェア、2023年・2033年(%)

5 創薬アウトソーシング市場分析：ワークフロー別
5.1 主要調査結果
5.2 ワークフロー・セグメント市場魅力度指数
5.3 ワークフロー別の創薬アウトソーシング市場規模の推定と予測
5.4 ターゲット同定とスクリーニング
5.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 ターゲットバリデーションと機能インフォマティクス
5.5.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 リード探索と候補化合物の最適化
5.6.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.6.2 地域別市場シェア、2023年・2033年(%)
5.7 前臨床開発
5.7.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.7.2 地域別市場シェア、2023年・2033年(%)
5.8 その他の関連ワークフロー
5.8.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.8.2 地域別市場シェア、2023年・2033年(%)

6 創薬アウトソーシング市場分析：治療分野別
6.1 主要調査結果
6.2 治療領域セグメント市場魅力度指数
6.3 治療領域別の創薬アウトソーシング市場規模の推定と予測
6.4 がん領域
6.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
6.4.2 地域別市場シェア、2023年・2033年 (%)
6.5 感染症
6.5.1 2023〜2033年の地域別市場予測 (US $ Mn, AGR %)
6.5.2 地域別市場シェア、2023年・2033年 (%)
6.6 中枢神経系
6.6.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
6.6.2 地域別市場シェア、2023年・2033年 (%)
6.7 免疫学
6.7.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
6.7.2 地域別市場シェア、2023年・2033年 (%)
6.8 循環器疾患
6.8.1 2023〜2033年の地域別市場予測 (US $ Mn, AGR %)
6.8.2 地域別市場シェア、2023年・2033年 (%)
6.9 代謝性疾患
6.9.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
6.9.2 地域別市場シェア、2023年・2033年 (%)
6.10 呼吸器疾患
6.10.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
6.10.2 地域別市場シェア、2023年・2033年 (%)
6.11 その他
6.11.1 2023年～2033年の地域別市場予測 (US$ Mn, AGR %)
6.11.2 地域別市場シェア、2023年・2033年 (%)

7 創薬アウトソーシング市場分析：分子タイプ別
7.1 主要な調査結果
7.2 分子タイプ別セグメント市場魅力度指数
7.3 分子タイプ別創薬アウトソーシング市場規模の推定と予測
7.4 大分子
7.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 低分子
7.5.1 2023～2033年の地域別市場予測 (US$ Mn, AGR %)
7.5.2 地域別市場シェア、2023年・2033年(%)

8 創薬アウトソーシング市場分析：エンドユーザー別
8.1 主要調査結果
8.2 エンドユーザーセグメント：市場魅力度指数
8.3 エンドユーザー別創薬アウトソーシング市場規模の推定と予測
8.4 製薬・バイオテクノロジー企業
8.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
8.4.2 地域別市場シェア、2023年・2033年
8.5 学術機関
8.5.1 2023～2033年の地域別市場予測 (US$ Mn, AGR %)
8.5.2 地域別市場シェア、2023年・2033年 (%)
8.6 その他
8.6.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
8.6.2 地域別市場シェア、2023・2033年 (%)

9 創薬アウトソーシング市場分析：地域別
9.1 主要な調査結果
9.2 地域別市場規模の推定と予測

10 北米の創薬アウトソーシング市場分析
10.1 主要な調査結果
10.2 北米の創薬アウトソーシング市場魅力度指数
10.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
10.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
10.5 市場規模推定と予測：サービスタイプ別、2023～2033年（US$ Mn）
10.6 市場規模推定と予測：ワークフロー別、2023～2033年（US$ Mn）
10.7 市場規模推定と予測：治療領域別、2023～2033年（US$ Mn）
10.8 市場規模推定と予測：分子タイプ別、2023～2033年（US$ Mn）
10.9 市場規模推定と予測：エンドユーザー別、2023～2033年（US$ Mn）
10.10 米国の創薬アウトソーシング市場分析
10.11 カナダの創薬アウトソーシング市場分析

11 欧州の創薬アウトソーシング市場分析
11.1 主要な調査結果
11.2 欧州創薬アウトソーシング市場魅力度指数
11.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
11.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
11.5 市場規模推定と予測：サービスタイプ別、2023〜2033年（US$ Mn）
11.6 市場規模推定と予測：ワークフロー別、2023-2033年（US$ Mn）
11.7 市場規模推定と予測：治療領域別、2023-2033年（US$ Mn）
11.8 市場規模推定と予測：分子タイプ別、2023-2033年 (US$ Mn)
11.9 市場規模推定と予測：エンドユーザー別、2023-2033年（US$ Mn）
11.10 ドイツの創薬アウトソーシング市場分析
11.11 イギリスの創薬アウトソーシング市場分析
11.12 フランスの創薬アウトソーシング市場分析
11.13 イタリアの創薬アウトソーシング市場分析
11.14 スペインの創薬アウトソーシング市場分析
11.15 ロシアの創薬アウトソーシング市場分析
11.16 その他の欧州の創薬アウトソーシング市場分析

12 アジア太平洋地域の創薬アウトソーシング市場分析
12.1 主要な調査結果
12.2 アジア太平洋地域の創薬アウトソーシング市場魅力度指数
12.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
12.4 市場規模推定と予測：国別、2023年〜2033年（US$ Mn）
12.5 市場規模推定と予測：サービスタイプ別、2023〜2033年（US$ Mn）
12.6 市場規模推定と予測：ワークフロー別、2023-2033年（US$ Mn）
12.7 市場規模推定と予測：治療領域別、2023-2033年（US$ Mn）
12.8 市場規模推定と予測：分子タイプ別、2023-2033年（US$ Mn）
12.9 市場規模推定と予測：エンドユーザー別、2023-2033年 (US$ Mn)
12.10 日本創薬アウトソーシング市場分析
12.11 中国の創薬アウトソーシング市場分析
12.12 インドの創薬アウトソーシング市場分析
12.13 オーストラリアの創薬アウトソーシング市場の分析
12.14 韓国創薬アウトソーシング市場の分析
12.15 東南アジアの創薬アウトソーシング市場分析
12.16 その他のアジア太平洋地域の創薬アウトソーシング市場分析

13 ラテンアメリカの創薬アウトソーシング市場分析
13.1 主要な調査結果
13.2 ラテンアメリカの創薬アウトソーシング市場魅力度指数
13.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
13.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
13.5 市場規模推定と予測：サービスタイプ別、2023〜2033年（US$ Mn）
13.6 市場規模推定と予測：ワークフロー別、2023-2033年（US$ Mn）
13.7 市場規模推定と予測：治療領域別、2023-2033年（US$ Mn）
13.8 市場規模推定と予測：分子タイプ別、2023-2033年（US$ Mn）
13.9 市場規模推定と予測：エンドユーザー別、2023-2033年（US$ Mn）
13.10 ブラジル創薬アウトソーシング市場分析
13.11 メキシコの創薬アウトソーシング市場分析
13.12 アルゼンチン創薬アウトソーシング市場分析
13.13 コロンビアの創薬アウトソーシング市場分析
13.14 その他のラテンアメリカの創薬アウトソーシング市場分析

14 MEAの創薬アウトソーシング市場分析
14.1 主要な調査結果
14.2 MEAの創薬アウトソーシング市場魅力度指数
14.3 市場規模：国別、2023年、2028年、2033年の（US$ Mn）
14.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
14.5 市場規模推定と予測：サービスタイプ別、2023〜2033年（US$ Mn）
14.6 市場規模推定と予測：ワークフロー別、2023-2033年（US$ Mn）
14.7 市場規模推定と予測：治療領域別、2023-2033年（US$ Mn）
14.8 市場規模推定と予測：分子タイプ別、2023-2033年（US$ Mn）
14.9 市場規模推定と予測：エンドユーザー別、2023-2033年（US$ Mn）
14.10 GCCの創薬アウトソーシング市場分析
14.11 南アフリカの創薬アウトソーシング市場分析
14.12 その他のMEAの創薬アウトソーシング市場分析

15 会社概要
15.1 Curia Global, Inc.
15.1.1 会社概要
15.1.2 会社概要
15.1.3 製品ベンチマーク
15.1.4 戦略的展望
15.2 Charles River Laboratories
15.2.1 会社概要
15.2.2 会社概要
15.2.3 財務分析
15.2.3.1 純収入、2015-2022年
15.2.3.2 地域市場シェア、2022年
15.2.4 製品ベンチマーク
15.2.5 戦略的展望
15.3 Dalton Pharma
15.3.1 会社概要
15.3.2 会社概要
15.3.3 製品ベンチマーク
15.3.4 戦略的展望
15.4 Domainex
15.4.1 会社概要
15.4.2 会社概要
15.4.3 製品ベンチマーク
15.4.4 戦略的展望
15.5 Eurofins
15.5.1 会社概要
15.5.2 会社概要
15.5.3 財務分析
15.5.3.1 純収入、2016-2022年
15.5.3.2 地域市場シェア、2022年
15.5.4 製品ベンチマーク
15.5.5 戦略的展望
15.6 Evotec AG
15.6.1 会社概要
15.6.2 会社概要
15.6.3 財務分析
15.6.3.1 純収入、2015-2022年
15.6.3.2 地域市場シェア、2022年
15.6.3.3 R＆D、2015-2022年
15.6.4 製品ベンチマーク
15.6.5 戦略的展望
15.7 Genscript
15.7.1 会社概要
15.7.2 会社概要
15.7.3 財務分析
15.7.3.1 純収入、2015-2022年
15.7.4 製品ベンチマーク
15.7.5 戦略的展望
15.8 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
15.8.1 会社のスナップショット
15.8.1 会社概要
15.8.2 会社概要
15.8.3 製品ベンチマーク
15.8.4 戦略的展望
15.9 Jubilant Biosys Ltd.
15.9.1 会社概要
15.9.2 会社概要
15.9.3 財務分析
15.9.3.1 純収入、2015-2020年
15.9.4 製品ベンチマーク
15.9.5 戦略的展望
15.10 Laboratory Corporation of America Holdings
15.10.1 会社概要
15.10.2 会社概要
15.10.3 財務分析
15.10.3.1 純収入、2015-2022年
15.10.3.2 地域市場シェア、2022年
15.10.4 製品ベンチマーク
15.10.5 戦略的展望
15.11 Pharmaron
15.11.1 会社概要
15.11.2 会社概要
15.11.3 財務分析
15.11.3.1 純収入、2016-2022年
15.11.4 製品ベンチマーク
15.11.5 戦略的展望
15.12 QIAGEN N.V.
15.12.1 会社概要
15.12.2 会社概要
15.12.3 財務分析
15.12.3.1 純収入、2015-2022年
15.12.3.2 売上高、2015-2022年
15.12.4 製品ベンチマーク
15.12.5 戦略的展望
15.13 Selvita
15.13.1 会社概要
15.13.2 会社概要
15.13.3 製品ベンチマーク
15.13.4 戦略的展望
15.14 Sundia Meditech Co Ltd.
15.14.1 会社概要
15.14.2 会社概要
15.14.3 製品ベンチマーク
15.15 Sygnature Discovery
15.15.1 会社概要
15.15.2 会社概要
15.15.3 製品ベンチマーク
15.15.4 戦略的展望
15.16 Syngene International
15.16.1 会社概要
15.16.2 会社概要
15.16.3 財務分析
15.16.3.1 純収入、2015-2022年
15.16.3.2 地域市場シェア、2022年
15.16.4 製品ベンチマーク
15.16.5 戦略的展望
15.17 Thermo Fisher Scientific Inc.
15.17.1 会社概要
15.17.2 会社概要
15.17.3 財務分析
15.17.3.1 純収入、2015-2022年
15.17.3.2 地域市場シェア、2022年
15.17.3.3 売上高、2015-2022年
15.17.4 製品ベンチマーク
15.17.5 戦略的展望
15.18 WuXi AppTec
15.18.1 会社概要
15.18.2 会社概要
15.18.3 財務分析
15.18.3.1 純収入、2015-2021年
15.18.3.2 地域市場シェア（2021年
15.18.4 製品ベンチマーク
15.18.5 戦略的展望

16 結論と提言
16.1 Visiongainからの結びの言葉
16.2 市場プレイヤーへの提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 Drug Discovery Outsourcing Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 3 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 4 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 5 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Drug Discovery Outsourcing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Curia Global, Inc.: Product Benchmarking
Table 84 Curia Global, Inc.: Strategic Outlook
Table 85 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Charles River Laboratories: Product Benchmarking
Table 87 Charles River Laboratories: Strategic Outlook
Table 88 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Dalton Pharma: Product Benchmarking
Table 90 Dalton Pharma: Strategic Outlook
Table 91 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Domainex: Product Benchmarking
Table 93 Domainex: Strategic Outlook
Table 94 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Eurofins: Product Benchmarking
Table 96 Eurofins: Strategic Outlook
Table 97 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Evotec AG: Product Benchmarking
Table 99 Evotec AG: Strategic Outlook
Table 100 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Genscript: Product Benchmarking
Table 102 Genscript: Strategic Outlook
Table 103 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Product Benchmarking
Table 105 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Strategic Outlook
Table 106 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Jubilant Biosys Ltd.: Product Benchmarking
Table 108 Jubilant Biosys Ltd.: Strategic Outlook
Table 109 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Laboratory Corporation of America Holdings: Product Benchmarking
Table 111 Laboratory Corporation of America Holdings: Strategic Outlook
Table 112 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Pharmaron: Product Benchmarking
Table 114 Pharmaron: Strategic Outlook
Table 115 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 QIAGEN N.V.: Product Benchmarking
Table 117 QIAGEN N.V.: Strategic Outlook
Table 118 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Selvita: Product Benchmarking
Table 120 Selvita: Strategic Outlook
Table 121 Sundia Meditech Co Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sundia Meditech Co Ltd.: Product Benchmarking
Table 123 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Sygnature Discovery: Product Benchmarking
Table 125 Sygnature Discovery: Strategic Outlook
Table 126 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Syngene International: Product Benchmarking
Table 128 Syngene International: Strategic Outlook
Table 129 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 131 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 132 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 WuXi AppTec: Product Benchmarking
Table 134 WuXi AppTec.: Strategic Outlook

図の一覧
Figure 1 Drug Discovery Outsourcing Market Segmentation
Figure 2 Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 3 Drug Discovery Outsourcing Market by Workflow: Market Attractiveness Index
Figure 4 Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 5 Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 6 Drug Discovery Outsourcing Market by End-users: Market Attractiveness Index
Figure 7 Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 8 Drug Discovery Outsourcing Market: Market Dynamics
Figure 9 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 10 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 11 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 12 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 13 Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 14 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 15 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 16 Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023, 2028, 2033 (%)
Figure 17 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Chemistry Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Biology Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 22 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 23 Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023, 2028, 2033 (%)
Figure 24 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Target Identification & Screening Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Target Validation & Functional Informatics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Lead Identification & Candidate Optimization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Preclinical Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Other Associated Workflow Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 35 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 36 Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 37 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Infectious Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Central Nervous System Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Metabolic Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Respiratory Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 54 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 55 Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023, 2028, 2033 (%)
Figure 56 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Large Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Small Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Drug Discovery Outsourcing Market Attractiveness Index by End-users
Figure 61 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 62 Drug Discovery Outsourcing Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 63 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 66 Academic Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 68 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Drug Discovery Outsourcing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Drug Discovery Outsourcing Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 71 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn)
Figure 72 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 73 North America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 74 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 75 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 77 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 78 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 79 North America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 80 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 81 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 82 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 83 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 84 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 85 North America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 86 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 89 Europe Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 90 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 91 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 92 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 93 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 94 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 95 Europe Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 96 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 97 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 98 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 99 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 100 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 101 Europe Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 102 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 110 Asia Pacific Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 111 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 112 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 114 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 115 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 116 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 117 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 118 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 119 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 120 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 121 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 122 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 123 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 131 Latin America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 132 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 133 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 135 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 136 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 137 Latin America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 138 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 139 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 140 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 141 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 142 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 143 Latin America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 144 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 146 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 147 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 150 MEA Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 151 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 152 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 153 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 154 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 155 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 156 MEA Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 157 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 158 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 159 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 160 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 161 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 162 MEA Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 163 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 164 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 165 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 Charles River Laboratories: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 167 Charles River Laboratories: Regional Market Share, 2022 (%)
Figure 168 Eurofins: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 169 Eurofins: Regional Market Share, 2022 (%)
Figure 170 Evotec AG: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 171 Evotec AG: Regional Market Share, 2022 (%)
Figure 172 Evotec AG: R&D, 2015-2022 (US$ million, AGR%)
Figure 173 Genscript: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 174 Jubilant Biosys Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 175 Laboratory Corporation of America Holdings: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 176 Laboratory Corporation of America Holdings: Regional Market Share, 2022 (%)
Figure 177 Pharmaron: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 178 QIAGEN N.V.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 179 QIAGEN N.V.: R&D, 2015-2022 (US$ million, AGR%)
Figure 180 Syngene International: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 181 Syngene International: Regional Market Share, 2022 (%)
Figure 182 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 183 Thermo Fisher Scientific Inc.: Regional Market Share, 2022 (%)
Figure 184 Thermo Fisher Scientific Inc.: R&D, 2015-2022 (US$ million, AGR%)
Figure 185 WuXi AppTec: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 WuXi AppTec: Regional Market Share, 2021 (%)

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The Drug Discovery Outsourcing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Faced with declining innovation and increasing financial pressure to reduce R&D expenditures across the board, pharmaceutical companies have realised that the top-down, blockbuster model of drug discovery is no longer viable. Therefore, there is currently a trend in the pharma market of shifting towards a more distributive model for R&D. In order to ensure future revenue growth, the pharmaceutical industry needs to refocus their investment on early drug discovery.

Public-private partnerships where companies form alliances with academic research laboratories have been suggested as the way forward. The advantage of this approach is that the results of drug discovery research would be made publicly available for everyone to see. The advantage of this approach is that the results of drug discovery research would be publicly available for everyone to see. This would leverage the expertise of global academia with the potential to arrive at therapies more quickly.

What Questions Should You Ask before Buying a Market Research Report?
• How is the drug discovery outsourcing market evolving?
• What is driving and restraining the drug discovery outsourcing market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each drug discovery outsourcing submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading drug discovery outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the drug discovery outsourcing projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
drug discovery outsourcing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
• Where is the drug discovery outsourcing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
• Our 389-page report provides 134 tables and 186 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Service Type
• Chemistry Services
• Biology Services

Workflow
• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development
• Other Associated Workflow

Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others

Molecule Type
• Large Molecules
• Small Molecules

End-users
• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
• Charles River Laboratories
• Curia Global, Inc.
• Dalton Pharma
• Domainex
• Eurofins
• Evotec AG
• Genscript
• Jubilant Biosys Ltd.
• Laboratory Corporation of America Holdings
• Pharmaron
• QIAGEN N.V.
• Selvita
• Sundia Meditech Co Ltd.
• Sygnature Discovery
• Syngene International
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Overall world revenue for Drug Discovery Outsourcing Market, 2023 to 2033 in terms of value the market will surpass US$10,644.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Drug Discovery Outsourcing Market, 2023 to 2033 report help you?
In summary, our 380+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Drug Discovery Outsourcing Market, 2023 to 2033 Market, with forecasts for service type, workflow, therapeutic area, molecule type, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 24 key national markets – See forecasts for the Drug Discovery Outsourcing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 18 of the major companies involved in the Drug Discovery Outsourcing Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Outsourcing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Reduced Pharmaceutical and Biotech R&D Budgets
3.2.1.2 Emerging Markets are a Popular Destination for CROs
3.2.1.3 Improving Conditions in the Industry will Drive Healthy Growth
3.2.1.4 Cost Reduction: A Central Driver for Outsourcing
3.2.1.5 Accelerating the Discovery of Drug Candidates
3.2.2 Market Restraining Factors
3.2.2.1 Limited IP Protection
3.2.2.2 Threat of Private Public Alliances
3.2.3 Market Opportunities
3.2.3.1 Strategic Partnerships to Offer Lucrative Growth Prospects
3.2.3.2 Investment in Artificial Intelligence to Offer Fresh Revenue Pockets
3.2.3.3 Available Scope for the Expansion of CROs
3.2.3.4 Targeted Therapies: Advances in Biologics and Orphan Drugs
3.3 COVID-19 Impact Analysis
3.4 R&D Outsourcing Business Model (Fee-for-Service)
3.5 Collaborations Between CRO and Pharmaceutical Industry
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry: High
3.6.2 Threat of Substitutes: Medium
3.6.3 Bargaining Power of Buyer: High
3.6.4 Bargaining Power of Suppliers: Medium
3.6.5 Threat of New Entrants: Medium

4 Drug Discovery Outsourcing Market Analysis by Service Type
4.1 Key Findings
4.2 Service Type Segment: Market Attractiveness Index
4.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Service Type
4.4 Chemistry Services
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Biology Services
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Drug Discovery Outsourcing Market Analysis by Workflow
5.1 Key Findings
5.2 Workflow Segment: Market Attractiveness Index
5.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Workflow
5.4 Target Identification & Screening
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Target Validation & Functional Informatics
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Lead Identification & Candidate Optimization
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Preclinical Development
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Other Associated Workflow
5.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Drug Discovery Outsourcing Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Infectious Disease
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Central Nervous System
6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Immunology
6.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Cardiovascular Disease
6.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Metabolic Disease
6.9.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.9.2 Market Share by Region, 2023 & 2033 (%)
6.10 Respiratory Disease
6.10.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.10.2 Market Share by Region, 2023 & 2033 (%)
6.11 Others
6.11.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.11.2 Market Share by Region, 2023 & 2033 (%)

7 Drug Discovery Outsourcing Market Analysis by Molecule Type
7.1 Key Findings
7.2 Molecule Type Segment: Market Attractiveness Index
7.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Molecule Type
7.4 Large Molecules
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Small Molecules
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.5.2 Market Share by Region, 2023 & 2033 (%)

8 Drug Discovery Outsourcing Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by End-users
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Academic Institutes
8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.6.2 Market Share by Region, 2023 & 2033 (%)

9 Drug Discovery Outsourcing Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Drug Discovery Outsourcing Market Analysis
10.1 Key Findings
10.2 North America Drug Discovery Outsourcing Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
10.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
10.10 U.S. Drug Discovery Outsourcing Market Analysis
10.11 Canada Drug Discovery Outsourcing Market Analysis

11 Europe Drug Discovery Outsourcing Market Analysis
11.1 Key Findings
11.2 Europe Drug Discovery Outsourcing Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
11.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
11.10 Germany Drug Discovery Outsourcing Market Analysis
11.11 UK Drug Discovery Outsourcing Market Analysis
11.12 France Drug Discovery Outsourcing Market Analysis
11.13 Italy Drug Discovery Outsourcing Market Analysis
11.14 Spain Drug Discovery Outsourcing Market Analysis
11.15 Russia Drug Discovery Outsourcing Market Analysis
11.16 Rest of Europe Drug Discovery Outsourcing Market Analysis

12 Asia Pacific Drug Discovery Outsourcing Market Analysis
12.1 Key Findings
12.2 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
12.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
12.10 Japan Drug Discovery Outsourcing Market Analysis
12.11 China Drug Discovery Outsourcing Market Analysis
12.12 India Drug Discovery Outsourcing Market Analysis
12.13 Australia Drug Discovery Outsourcing Market Analysis
12.14 South Korea Drug Discovery Outsourcing Market Analysis
12.15 South-East Asia Drug Discovery Outsourcing Market Analysis
12.16 Rest of Asia Pacific Drug Discovery Outsourcing Market Analysis

13 Latin America Drug Discovery Outsourcing Market Analysis
13.1 Key Findings
13.2 Latin America Drug Discovery Outsourcing Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
13.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
13.10 Brazil Drug Discovery Outsourcing Market Analysis
13.11 Mexico Drug Discovery Outsourcing Market Analysis
13.12 Argentina Drug Discovery Outsourcing Market Analysis
13.13 Colombia Drug Discovery Outsourcing Market Analysis
13.14 Rest of Latin America Drug Discovery Outsourcing Market Analysis

14 MEA Drug Discovery Outsourcing Market Analysis
14.1 Key Findings
14.2 MEA Drug Discovery Outsourcing Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
14.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
14.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
14.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
14.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
14.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
14.10 GCC Drug Discovery Outsourcing Market Analysis
14.11 South Africa Drug Discovery Outsourcing Market Analysis
14.12 Rest of MEA Drug Discovery Outsourcing Market Analysis

15 Company Profiles
15.1 Curia Global, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Product Benchmarking
15.1.4 Strategic Outlook
15.2 Charles River Laboratories
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2015-2022
15.2.3.2 Regional Market Share, 2022
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Dalton Pharma
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Product Benchmarking
15.3.4 Strategic Outlook
15.4 Domainex
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Product Benchmarking
15.4.4 Strategic Outlook
15.5 Eurofins
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2022
15.5.3.2 Regional Market Share, 2022
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Evotec AG
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2015-2022
15.6.3.2 Regional Market Share, 2022
15.6.3.3 R&D, 2015-2022
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Genscript
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2022
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Strategic Outlook
15.9 Jubilant Biosys Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2015-2020
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Laboratory Corporation of America Holdings
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2015-2022
15.10.3.2 Regional Market Share, 2022
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Pharmaron
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2016-2022
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 QIAGEN N.V.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2015-2022
15.12.3.2 R&D, 2015-2022
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Selvita
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Product Benchmarking
15.13.4 Strategic Outlook
15.14 Sundia Meditech Co Ltd.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.15 Sygnature Discovery
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Strategic Outlook
15.16 Syngene International
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2015-2022
15.16.3.2 Regional Market Share, 2022
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 Thermo Fisher Scientific Inc.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2015-2022
15.17.3.2 Regional Market Share, 2022
15.17.3.3 R&D, 2015-2022
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 WuXi AppTec
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2021
15.18.3.2 Regional Market Share, 2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Drug Discovery Outsourcing Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 3 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 4 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 5 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Drug Discovery Outsourcing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Curia Global, Inc.: Product Benchmarking
Table 84 Curia Global, Inc.: Strategic Outlook
Table 85 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Charles River Laboratories: Product Benchmarking
Table 87 Charles River Laboratories: Strategic Outlook
Table 88 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Dalton Pharma: Product Benchmarking
Table 90 Dalton Pharma: Strategic Outlook
Table 91 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Domainex: Product Benchmarking
Table 93 Domainex: Strategic Outlook
Table 94 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Eurofins: Product Benchmarking
Table 96 Eurofins: Strategic Outlook
Table 97 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Evotec AG: Product Benchmarking
Table 99 Evotec AG: Strategic Outlook
Table 100 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Genscript: Product Benchmarking
Table 102 Genscript: Strategic Outlook
Table 103 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Product Benchmarking
Table 105 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Strategic Outlook
Table 106 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Jubilant Biosys Ltd.: Product Benchmarking
Table 108 Jubilant Biosys Ltd.: Strategic Outlook
Table 109 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Laboratory Corporation of America Holdings: Product Benchmarking
Table 111 Laboratory Corporation of America Holdings: Strategic Outlook
Table 112 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Pharmaron: Product Benchmarking
Table 114 Pharmaron: Strategic Outlook
Table 115 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 QIAGEN N.V.: Product Benchmarking
Table 117 QIAGEN N.V.: Strategic Outlook
Table 118 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Selvita: Product Benchmarking
Table 120 Selvita: Strategic Outlook
Table 121 Sundia Meditech Co Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sundia Meditech Co Ltd.: Product Benchmarking
Table 123 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Sygnature Discovery: Product Benchmarking
Table 125 Sygnature Discovery: Strategic Outlook
Table 126 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Syngene International: Product Benchmarking
Table 128 Syngene International: Strategic Outlook
Table 129 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 131 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 132 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 WuXi AppTec: Product Benchmarking
Table 134 WuXi AppTec.: Strategic Outlook

List of Figures
Figure 1 Drug Discovery Outsourcing Market Segmentation
Figure 2 Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 3 Drug Discovery Outsourcing Market by Workflow: Market Attractiveness Index
Figure 4 Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 5 Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 6 Drug Discovery Outsourcing Market by End-users: Market Attractiveness Index
Figure 7 Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 8 Drug Discovery Outsourcing Market: Market Dynamics
Figure 9 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 10 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 11 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 12 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 13 Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 14 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 15 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 16 Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023, 2028, 2033 (%)
Figure 17 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Chemistry Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Biology Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 22 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 23 Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023, 2028, 2033 (%)
Figure 24 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Target Identification & Screening Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Target Validation & Functional Informatics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Lead Identification & Candidate Optimization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Preclinical Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Other Associated Workflow Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 35 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 36 Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 37 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Infectious Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Central Nervous System Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Metabolic Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Respiratory Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 54 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 55 Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023, 2028, 2033 (%)
Figure 56 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Large Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Small Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Drug Discovery Outsourcing Market Attractiveness Index by End-users
Figure 61 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 62 Drug Discovery Outsourcing Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 63 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 66 Academic Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 68 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Drug Discovery Outsourcing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Drug Discovery Outsourcing Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 71 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn)
Figure 72 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 73 North America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 74 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 75 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 77 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 78 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 79 North America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 80 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 81 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 82 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 83 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 84 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 85 North America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 86 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 89 Europe Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 90 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 91 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 92 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 93 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 94 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 95 Europe Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 96 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 97 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 98 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 99 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 100 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 101 Europe Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 102 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 110 Asia Pacific Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 111 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 112 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 114 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 115 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 116 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 117 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 118 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 119 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 120 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 121 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 122 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 123 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 131 Latin America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 132 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 133 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 135 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 136 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 137 Latin America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 138 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 139 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 140 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 141 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 142 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 143 Latin America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 144 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 146 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 147 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 150 MEA Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 151 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 152 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 153 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 154 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 155 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 156 MEA Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 157 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 158 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 159 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 160 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 161 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 162 MEA Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 163 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 164 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 165 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 Charles River Laboratories: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 167 Charles River Laboratories: Regional Market Share, 2022 (%)
Figure 168 Eurofins: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 169 Eurofins: Regional Market Share, 2022 (%)
Figure 170 Evotec AG: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 171 Evotec AG: Regional Market Share, 2022 (%)
Figure 172 Evotec AG: R&D, 2015-2022 (US$ million, AGR%)
Figure 173 Genscript: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 174 Jubilant Biosys Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 175 Laboratory Corporation of America Holdings: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 176 Laboratory Corporation of America Holdings: Regional Market Share, 2022 (%)
Figure 177 Pharmaron: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 178 QIAGEN N.V.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 179 QIAGEN N.V.: R&D, 2015-2022 (US$ million, AGR%)
Figure 180 Syngene International: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 181 Syngene International: Regional Market Share, 2022 (%)
Figure 182 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 183 Thermo Fisher Scientific Inc.: Regional Market Share, 2022 (%)
Figure 184 Thermo Fisher Scientific Inc.: R&D, 2015-2022 (US$ million, AGR%)
Figure 185 WuXi AppTec: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 WuXi AppTec: Regional Market Share, 2021 (%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（biotechnology）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

創薬アウトソーシング市場レポート 2023-2033

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（biotechnology）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?